Steps Forward in 2026 with The Market Structure Bill

Chicago, January 29, 2026—Amplify ETFs announces January income distributions for its income ETFs.

NDIV targets 10% or greater total annualized income from dividends and option premiums

Audio Commentary by Tim Seymour

Market and Economic Update - Earnings strength, shifting Fed expectations, and active commodities shaped a volatile but constructive past month

The Amplify Weight Loss Drug & Treatment ETF (THNR) seeks investments results that generally correspond to the performance of the VettaFi Weight Loss Drug & Treatment Index. THNR provides access to global companies involved in the pharmaceutical manufacturing of GLP-1 agonist or enablers of such businesses.

Audio Commentary by Tim Seymour

Amplify LQD Investment Grade 12% Target Income ETF (LQDM) and Amplify HYG High Yield 10% Target Income ETF (HYGM)

Blockchain Convergence with AI